Scholarlink

<p>Hepatocellular carcinoma (HCC), the most common primary liver cancer, presents treatment challenges due to its complexity and marginal liver function. Robotic liver resection has emerged as promising for HCC, but its long-term efficacy requires investigation. Some reports cite a 5-year overall survival of 38.5% following open resection for HCC. This study aims to evaluate the long-term outcomes of robotic liver resection for HCC in our institution. After IRB approval, we retrospectively analyzed consecutive patients who underwent robotic liver resections for HCC between 2013 and March 2024 at a high-volume institution. Patients with less than 90 days of follow-up were excluded from the study. Among 81 patients, the mean age was 68 years, and 23% were women. Hepatitis B and C were present in 3 (4%) and 36 (45%) patients, respectively, while 11 (13.6%) had cirrhosis. Ten (12.3%) were Child-Pugh A, and the IWATE score ranged from 2 to 12 points, with a mean of 8. Tumor size had a mean of 5&#xa0;cm. One unplanned conversion to an open approach was documented. No intraoperative complications were noted. 8 (10%) operations resulted in postoperative complications. The mean length of stay was 5 days, with a mean follow-up of 31 months. Kaplan-Meier survival analysis demonstrated 3-year overall survival at 65% and 5-year survival at 54%. Robotic liver resection for HCC is a feasible and safe approach, which offers promising long-term outcomes with low morbidity and complication rates.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Transforming liver cancer care: long-term outcomes of robotic liver resection for hepatocellular cancer

  • 期刊论文

  • 发表日期：

    2026年3月5日

查看全文
  • Kristina Milivojev Covilo,
  • Andrew J. Kim,
  • Sharona B. Ross,
  • Garnet Vanterpool Jr.,
  • Alona Bilik,
  • Iswanto Sucandy

摘要

Hepatocellular carcinoma (HCC), the most common primary liver cancer, presents treatment challenges due to its complexity and marginal liver function. Robotic liver resection has emerged as promising for HCC, but its long-term efficacy requires investigation. Some reports cite a 5-year overall survival of 38.5% following open resection for HCC. This study aims to evaluate the long-term outcomes of robotic liver resection for HCC in our institution. After IRB approval, we retrospectively analyzed consecutive patients who underwent robotic liver resections for HCC between 2013 and March 2024 at a high-volume institution. Patients with less than 90 days of follow-up were excluded from the study. Among 81 patients, the mean age was 68 years, and 23% were women. Hepatitis B and C were present in 3 (4%) and 36 (45%) patients, respectively, while 11 (13.6%) had cirrhosis. Ten (12.3%) were Child-Pugh A, and the IWATE score ranged from 2 to 12 points, with a mean of 8. Tumor size had a mean of 5 cm. One unplanned conversion to an open approach was documented. No intraoperative complications were noted. 8 (10%) operations resulted in postoperative complications. The mean length of stay was 5 days, with a mean follow-up of 31 months. Kaplan-Meier survival analysis demonstrated 3-year overall survival at 65% and 5-year survival at 54%. Robotic liver resection for HCC is a feasible and safe approach, which offers promising long-term outcomes with low morbidity and complication rates.